NSE: SUNPHARMA

Sun Pharma: The Specialty Pivot and the Heavyweight Prescription for Growth

By StreetVantage Intelligence // August 6, 2026

₹₹1,951.00

BULLISH

DISCLAIMER: Educational intelligence only. StreetVantage is NOT SEBI registered. Trading involve risk of loss.